1990PubMedRequires access

Itraconazole in dermatophyte infections: clinical experience in Italy.

E. M. Difonzo, E Panconesi, P. Cilli

Open publisher page 5 citations

Abstract

Approximately 200 patients with clinically and mycologically diagnosed dermatophytoses were treated with itraconazole. The drug was administered at a dose of 100 mg with the main meal. Therapy duration was as follows: tinea corporis and tinea cruris, 14 days; tinea pedis and tinea manuum, 28 days; tinea unguium of hands, three months, and feet, six months; tinea capitis, 30 days. Clinical and mycological control tests (eg, direct microscopy and culture) were performed prior to treatment, at the end of treatment and two and four weeks after the end of treatment. Blood chemistry parameters were measured before and at the end of treatment. The results of the research presented here mirror exactly those of international research and therefore confirm that itraconazole is both active and well tolerated in the treatment of dermatophytoses.

About this research paper

What this paper is about

Approximately 200 patients with clinically and mycologically diagnosed dermatophytoses were treated with itraconazole. The drug was administered at a dose of 100 mg with the main meal. Therapy duration was as follows: tinea corporis and tinea cruris, 14 days; tinea pedis and tinea manuum, 28 days; tinea unguium of hands, three months, and feet, six months; tinea capitis, 30 days. Clinical and mycological control tests (eg, direct microscopy and culture) were performed prior to treatment, at the end of treatment and two and four weeks after the end of treatment. Blood chemistry parameters were measured before and at the end of treatment. The results of the research presented here mirror exactly those of international research and therefore confirm that itraconazole is both active and well tolerated in the treatment of dermatophytoses.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Approximately 200 patients with clinically and mycologically diagnosed dermatophytoses were treated with itraconazole. The drug was administered at a dose of 100 mg with the main meal. Therapy duration was as follows: tinea corporis and tinea cruris, 14 days; tinea pedis and tinea manuum, 28 days; tinea unguium of hands, three months, and feet, six months; tinea capitis, 30 days. Clinical and mycological control tests (eg, direct microscopy and culture) were performed prior to treatment, at the end of treatment and two and four weeks after the end of treatment. Blood chemistry parameters were measured before and at the end of treatment. The results of the research presented here mirror exactly those of international research and therefore confirm that itraconazole is both active and well tolerated in the treatment of dermatophytoses.

Key concepts: Itraconazole, Tinea capitis, Medicine, Dermatophyte, Dermatology, Mycosis, Trichophyton rubrum, Antifungal

Related papers

Back to paper searchBrowse research topicsOriginal source
Itraconazole in dermatophyte infections: clinical experience in Italy. — Research Paper | ScholarLens